Fact CheckerSign in

NCT03634397Completed

Predicting Ipsilesional Motor Deficits in Stroke With Dynamic Dominance Model

Source: ClinicalTrials.gov · Last updated 12 Sept 2025

Brief summary (registry, in English)

This study will test the hypothesis that the combination of low-moderate to severe motor deficits in the paretic arm and persistent motor deficits in the less-impaired arm limits functional independence in chronic stroke survivors. We, therefore, predict that intense remediation, focused on improving the speed, coordination, and accuracy of the less-impaired arm should improve functional independence.

Status (registry)
Completed
Study type
Interventional
Enrollment
58 (actual)
First submitted
3 Jul 2018
Start date
2 Feb 2019
Primary completion date
22 Feb 2024
Lead sponsor
Robert L. Sainburg
Diseases
Stroke
NCT number
NCT03634397

What you commit to

  • Study type: Interventional
  • Participants enrolled: 58
  • From 2 Feb 2019 to the primary completion date, 22 Feb 2024
  • 2 sites in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • currently taking prescription drugs with known sedative properties that are interfering with sensory-motor function

Other illness

  • a history of:
  • neurological disease other than stroke (e.g., head trauma)
  • a major psychiatric diagnosis (e.g., schizophrenia, major affective disorder),
  • peripheral disorders affecting sensation or movement of the upper extremities, including pain or arthritis
  • bilateral stroke

Other

  • hospital admission for substance abuse
  • significant joint pain that is activity limiting

Who the study is looking for

  • neuroradiological confirmation of unilateral brain damage with residual contralesional upper-extremity weakness
  • deficits in ipsilesional arm performance assessed by the JTHFT
  • 6+ months post stroke
  • Demonstrates cognitive abilities

Age in the registry: 18 years to 85 years · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (2)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Penn State College of Medicine
Coordinator of this site? Confirm its status
HersheyUnited StatesUnknown status
University of Southern California
Coordinator of this site? Confirm its status
Los AngelesUnited StatesUnknown status

Related publications

This page is information, not medical advice. Discuss any trial with your doctor.